Nestec Ltd

Clintec Nutrition Company

Baxter International Inc.

Nestec S.a.

Baxter Travenol Laboratories, Inc.

Free Radical Sciences

David C Madsen

Hugh N Tucker

W Bruce Rowe

Susan L Trimbo

David A Mark

Robert C Johnson

Michael D Ward

Richard Cotter

Diana Twyman

Shen-Youn Chang

Chris Kruzel

Dennis I Goldberg

Theresa Voss

Michael P Menard

Kathryn Hennessy

Carol Siegel

Anthony J Valicenti

Michael Ward

A system and a method are provided for monitoring a patient. The system receives information relating to weight and/or LBM of a patient as well as other clinical and medical variable may be input relating to the patient. Warning levels or alert levels are input to the system such that a patient or clinician is immediately notified upon the patient reaching such levels. The system provides local transmission to a patient or remote transmission to, for example, a clinician of the patient or the like. The system and method are particularly useful for patients with chronic disease such that the dynamic nutritional status may be closely monitored and analyzed and ultimately addressed when significant changes occur.

System and method for monitoring and analyzing dynamic nutritional

A method is provided for increasing and/or maintaining the level of intracellular glutathione. Pursuant to the invention, compositions including denatured and at least partially hydrolyzed proteins are administered to a patient in an amount sufficient to increase glutathione levels in the patient.

Method for insuring adequate intracellular glutathione in tissue

The present invention provides a composition as well as method for providing nutrition to renal patients. Pursuant to the present invention, the enteral composition includes an effective amount of a protein source including whey protein and free amino acids that provide essential as well as nonessential amino acids. The composition is calorically dense and has a moderate osmolality.

Method and composition for providing nutrition to a renal failure patient

The present invention provides a method for reducing and controlling antigen-specific immunoglobulin concentrations in a patient. In addition, the present invention provides a method for maintaining physiological functions of the intestine in a patient. Pursuant to the present invention, the composition includes a protein source, a carbohydrate source, a fat source, and a specialized vitamin and mineral profile.

Method for reducing and controlling immunoglobulin concentrations

The present invention provides a method of treating infertility comprising administering to a female mammal having fertility problems a therapeutically effective amount of the glutathione stimulator L-2-oxothiazolidine-4-carboxylate or esters thereof.

Method for treating infertility

A nutritional composition is provided that is low ammoniagenic, scavenges ammonia well, and yet does not contribute to excess nitric oxide production. The nutritional composition includes an amino acid profile having less than 20 percent of the total amino acids as ammoniagenic amino acids. The nutritional composition also includes less than 0.2 percent of the total amino acids as arginine and at least 0.2 percent of the total amino acids as ornithine and/citrulline.

Nutritional compositions for management of nitrogen metabolism

The present invention relates to nutrient compositions containing dipeptides and methods for administering the same. In particular, according to the present invention, a nutrient composition comprising an aqueous solution having at least one dipeptide with an N-terminal amino acid selected from the class consisting of glutamine, asparagine, tyrosine, tryptophan, and aspargine is provided. Glutamine (4.8 grams/100 ml at 30.degree. C.), asparagine (3.5 grams/100 mL at 28.degree. C.), tyrosine (0.45 grams/100 mL at 25.degree. C.) and tryptophan (11.4 grams/100 mL at 25.degree. C.) and arginine (15.0 grams/100 mL at 21.degree. C.) are all less soluble in water than glycine (25 grams/100 mL at 25.degree. C.). The C-terminal amino acid is selected from the group consisting of alanine, glycine, tryptophan, arginine, proline and serine. The nutritional solutions contain from about 0.1 to 25.0 percent by weight of oligopeptides, preferably about 0.5 to 5.0 percent by weight.

Nutrient compositions containing peptides and method for administering

The present invention provides a method for treating and/or reducing ischemic reperfusion injury. To this end, in embodiment, a method for treating and/or reducing reperfusion injury is provided comprising the step of administering to a patient in danger of reperfusion injury a therapeutically effective amount of L-2-oxothiazolidine-4-carboxylic acid. In an embodiment, a method is provided for limiting an expected ischemic reperfusion injury comprising the step of administering prior to an expected ischemic event a therapeutically effective amount of L-2-oxothiazolidine-4-carboxylic acid. In a further embodiment of the present invention, a method is provided for limiting ischemic reperfusion injury comprising the step of administering to a patient after the onset of an ischemic event a therapeutically effective amount of L-2-oxothiazolidine-4-carboxylic acid.

Method for treating reperfusion injury employing

A method is provided for individuals under treatment for or at risk of atherosclerotic, vascular, cardiovascular, and/or thrombotic disease by administering a composition which comprises a protein source; a carbohydrate source; and at least one lipid selected from the group consisting of: gamma-linolenic acid; eicosapentaenoic acid; docosahexaenoic acid; sterodonic acid; and linolenic acid. Both an enteral and parenteral composition are provided.

Nutritional support or therapy for individuals at risk or under

Nutritional compositions for management of hepatic failure are improved by eliminating certain ammonotelic amino acids and reducing the proportion of essential ammonotelic amino acids. A composition is provided which is optimized for nutritional therapy and suppression of hyperammonemia.

Nurtitional composition for management of hepatic failure

A novel amino acid composition is provided for the nutritional maintenance of renal failure patients.

Growing community of inventors

Libertyville, IL, United States of America

David C Madsen